Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HORNEMAN-THIELCKE KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.3% 1.3%   Bankruptcy risk   8.2% 7.4% 9.3% 12.1% 13.6% 6.9% 16.5% 16.5%   Credit score (0-100)   31 34 26 18 16 34 11 11   Credit rating   BB BB BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   831 735 0 0 0 0 0 0   Gross profit   482 410 437 347 346 364 0.0 0.0   EBITDA   136 74.9 100 12.9 8.1 23.5 0.0 0.0   EBIT   136 74.9 100 12.9 8.1 23.5 0.0 0.0   Pre-tax profit (PTP)   136.4 74.9 100.2 12.4 5.7 22.0 0.0 0.0   Net earnings   104.9 56.5 77.0 9.8 4.5 16.8 0.0 0.0   Pre-tax profit without non-rec. items   136 74.9 100 12.4 5.7 22.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   399 402 423 377 325 281 217 217   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   596 567 753 724 528 472 217 217   Net Debt   -596 -555 -753 -724 -494 -470 -217 -217     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   831 735 0 0 0 0 0 0   Net sales growth   -1.5% -11.5% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   482 410 437 347 346 364 0.0 0.0   Gross profit growth   -13.6% -15.0% 6.7% -20.7% -0.1% 5.3% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   596 567 753 724 528 472 217 217   Balance sheet change%   6.6% -5.0% 32.9% -3.8% -27.1% -10.6% -54.1% 0.0%   Added value   136.4 74.9 100.2 12.9 8.1 23.5 0.0 0.0   Added value %   16.4% 10.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   -1.0 -2.0 -3.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   16.4% 10.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   16.4% 10.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.3% 18.3% 22.9% 3.7% 2.4% 6.4% 0.0% 0.0%   Net Earnings %   12.6% 7.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   12.6% 7.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   16.4% 10.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.6% 12.9% 15.2% 1.7% 1.3% 4.7% 0.0% 0.0%   ROI %   36.5% 18.7% 24.3% 3.2% 2.3% 7.8% 0.0% 0.0%   ROE %   28.1% 14.1% 18.7% 2.4% 1.3% 5.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   66.9% 70.9% 56.1% 52.0% 61.6% 59.5% 100.0% 100.0%   Relative indebtedness %   23.7% 22.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   -48.1% -53.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -437.3% -741.0% -751.7% -5,610.8% -6,074.8% -2,003.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.0 3.4 2.3 2.1 2.6 2.5 0.0 0.0   Current Ratio   3.0 3.4 2.3 2.1 2.6 2.5 0.0 0.0   Cash and cash equivalent   596.5 555.3 753.0 724.1 494.3 470.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   6.6 15.7 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   71.8% 77.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   399.3 401.8 422.8 376.6 325.1 280.9 0.0 0.0   Net working capital %   48.1% 54.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0